Srinivas Vourganti to Magnetic Resonance Imaging
This is a "connection" page, showing publications Srinivas Vourganti has written about Magnetic Resonance Imaging.
Connection Strength
1.393
-
Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol. 2012 Dec; 188(6):2152-2157.
Score: 0.279
-
Pro: Magnetic Resonance Imaging Targeting Leads to Overtreatment of Prostate Cancer. J Urol. 2022 08; 208(2):246-247.
Score: 0.135
-
Urology Residents' Experience With Simulation: Initial Evaluation of MRI/US Fusion Biopsy Workshop. Urology. 2019 Dec; 134:51-55.
Score: 0.113
-
Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis. Urol Oncol. 2018 Jul; 36(7):341.e1-341.e7.
Score: 0.102
-
Spatial Tracking of Targeted Prostate Biopsy Locations: Moving Towards Effective Focal Partial Prostate Gland Ablation with Improved Treatment Planning. Curr Urol Rep. 2017 Oct 18; 18(12):93.
Score: 0.099
-
MR/US Fusion Technology: What Makes It Tick? Curr Urol Rep. 2017 Mar; 18(3):20.
Score: 0.094
-
Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies. BJU Int. 2015 Mar; 115(3):381-8.
Score: 0.080
-
Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up. Diagn Interv Radiol. 2014 Jul-Aug; 20(4):293-8.
Score: 0.078
-
MRI characterization of the dynamic effects of 5a-reductase inhibitors on prostate zonal volumes. Can J Urol. 2013 Dec; 20(6):7002-7.
Score: 0.075
-
Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? J Urol. 2013 Dec; 190(6):2020-2025.
Score: 0.073
-
Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol. 2013 Nov; 190(5):1721-1727.
Score: 0.073
-
Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int. 2012 Dec; 110(11 Pt B):E783-8.
Score: 0.070
-
Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients. BJU Int. 2012 Dec; 110(11):1642-7.
Score: 0.069
-
Multi-institutional analysis of clinical and imaging risk factors for detecting clinically significant prostate cancer in men with PI-RADS 3 lesions. Cancer. 2022 09 15; 128(18):3287-3296.
Score: 0.034
-
Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer. 2013 Sep 15; 119(18):3359-66.
Score: 0.018